Uncategorized
Compounding Lab
@CompoundingLabTracked since Jul 2026
Investment research, charts, valuation models.
Observed Aug 20, 2026 · staleModeled revenue
Paid members
Unavailable
growth unavailable
Total audience
Unavailable
not publicly listed
Monthly gross
Unavailable
Starting price
€5/mo
3 membership tiers
Pricing and benefits captured publicly
Membership tiersPatreon is not exposing patron counts by tier for this creator, so this section shows public prices and benefits only.
€0/moFreePublic prices and benefits only
€5/moBasicAccess to my own portfolio performance and holdingsFull library of visualsReal-Time Trade Alerts: Get immediate access to the exact trades I’m making, along with my analysis, so you can learn the "why" behind every moveDiscuss my thoughts on the marketShare my knowledge with subscribers who wish to learn investment analysis3-5 visuals uploaded weeklyOne DCF valuation model per week1 free stock review (OnePager) upon your requestPrivate Chat groupEducational Resources: Access a library of guides and PDFs designed to boost your trading knowledge and sharpen your skills
€40/moAdvancedEverything included in Basic, plus:Direct Access to My expertise: Enjoy a personal line of communication for questions whenever you need it so you can trade with confidence and stay on trackDirect link to my Etoro page, where Non-US residents can copy my portfolioDCF valuation model for selected stockP.S. Historical performance is not indicative of future returns
Growth signals: Compounding Lab
Not measurable
MembershipLast observed 2026-08-20. Not enough recent observation yet for a 30-day reading.
010
Jul 20268 weeks trackedNow
Compounding Labmembers unavailable · revenue unavailable
The chart only uses Compounding Lab's observed public history. Comparison peers are listed below, but comparable trend series are not available yet.
Where Compounding Lab ranks
Creator comparisonsCompare within
Not enough data0 of 1 cohort creators measured
Paid members in Recommended cohort
Semantic matches are not ready, so this fixed cohort uses the best available category, audience, pricing, and cadence evidence.
No comparable peer is available yet, so Compounding Lab's cohort rank cannot be calculated.Ranking data · includes stale rows| Rank | Creator and why included | Paid members | Gap vs Compounding Lab | Freshness |
|---|---|---|---|---|
| Not ranked |  Compounding LabProfileUncategorizedPaid members position in Recommended cohort | Not measured | Reference | Aug 20, 2026Stale |
The rank uses the full fixed cohort. This table shows up to five creators around Compounding Lab; the coverage summary above still counts everyone.
Recent posts
What they publish252Profile posts0 postsLast month0%Members-only
Previews available for 20 of 252 posts
Article Latest postPublic$DPZ DCF valuation modelMarch 19
March 19 0 likes 0 comments$ZTSMarch 19 View post 10Y ROIC, Average 19% ☑ 10Y Revenue, CAGR 7% ☑ FCFE 3Y Average, per share $4.6 FCF 3Y yield 4% Wide Moat ☑ Market Price $117 Fair value $162 Shares UNDERVALUED Discount (-)/Premium (+) -28% ☑ArticleMarch 19Public 0 0$DISMarch 18 View post 10Y ROIC, Average 8% 🚫 10Y Revenue, CAGR 6% ☑ FCFE 3Y Average, per share $4.3 FCF 3Y yield 4% Wide Moat ☑ Market Price $99 Fair value $119 Shares UNDERVALUED Discount (-)/Premium (+) -16% ☑ArticleMarch 18Public 0 010Y ROIC, Average 15%$UL March 17 View post 10Y ROIC, Average 15% 10Y Revenue, CAGR -1% FCFE 3Y Average, per share $3.0 FCF 3Y yield 5% Wide Moat Market Price $65 Fair value $67 Shares FAIRLY VALUED Discount (-)/Premium (+) -2%ArticleMarch 17Public 0 0$RELXMarch 17 View post 10Y ROIC, Average 16% 10Y Revenue, CAGR 5% FCFE 3Y Average, per share $1.3 FCF 3Y yield 4% Wide Moat Market Price $34 Fair value $54 Shares UNDERVALUED Discount (-)/Premium (+) -37%ArticleMarch 17Public 0 010Y ROIC, Average 14%$BR March 16 View post 10Y ROIC, Average 14% 10Y Revenue, CAGR 10% FCFE 3Y Average, per share $7.8 FCF 3Y yield 4% Wide Moat Market Price $179 Fair value $276 Shares UNDERVALUED Discount (-)/Premium (+) -35%ArticleMarch 16Public 0 0$VEEVMarch 16 View post 10Y ROIC, Average 14% 10Y Revenue, CAGR 23% FCFE 3Y Average, per share $6.9 FCF 3Y yield 4% Wide Moat Market Price $185 Fair value $273 Shares UNDERVALUED Discount (-)/Premium (+) -32%ArticleMarch 16Public 0 0$SAPMarch 15 View post 10Y ROIC, Average 9% 10Y ROIC, Coefficient of variation 30% FCFE 3Y Average, per share $5.2 FCF 3Y yield 3% Wide Moat Market Price $190 Fair value $301 Shares UNDERVALUED Discount (-)/Premium (+) -37%ArticleMarch 15Public 0 0$FDS - onepagerMarch 15 View post 10Y ROIC, Average 23% 10Y Revenue, CAGR 9% FCFE 3Y Average, per share $15.9 FCF 3Y yield 8% Narrow Moat Market Price $204 Fair value $261 Shares UNDERVALUED Discount (-)/Premium (+) -22%ArticleMarch 15Public 0 0$BF.B - onepagerNo one should be surprised by the declining price of Brown-Forman Corp.Articlemarket.
7Public 0 0$CSGPMarch 15 View post 10Y ROIC, Average 4% 10Y Revenue, CAGR 16% FCFE 3Y Average, per share $0.2 FCF 3Y yield 0% Wide Moat Market Price $44 Fair value $72 Shares UNDERVALUED Discount (-)/Premium (+) -40%ArticleMarch 15Public 0 0$MELI DCF valuation model - updatedMarch 15ArticleMarch 15Public 0 0
Research actions
Work with this creator
Save, compare, or return to the Explore view you came from.